{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:34:39Z","timestamp":1771040079992,"version":"3.50.1"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015763","name":"Leukaemia UK","doi-asserted-by":"publisher","award":["PG17\/002"],"award-info":[{"award-number":["PG17\/002"]}],"id":[{"id":"10.13039\/100015763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015570","name":"Blood Cancer UK","doi-asserted-by":"publisher","award":["13042"],"award-info":[{"award-number":["13042"]}],"id":[{"id":"10.13039\/501100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015570","name":"Blood Cancer UK","doi-asserted-by":"publisher","award":["19004"],"award-info":[{"award-number":["19004"]}],"id":[{"id":"10.13039\/501100015570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jbior.2023.100993","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:32:07Z","timestamp":1695781927000},"page":"100993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies"],"prefix":"10.1016","volume":"91","author":[{"given":"Dharamveer","family":"Tatwavedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pellagatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-2928","authenticated-orcid":false,"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jbior.2023.100993_bib1","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2009-06-227629","article-title":"Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome","volume":"115","author":"Alford","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/hmg\/8.5.743","article-title":"Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA\/A)","volume":"8","author":"Allikmets","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"7519","key":"10.1016\/j.jbior.2023.100993_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature13579","article-title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease","volume":"513","author":"Anders","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jbior.2023.100993_bib4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/blood-2015-09-671172","article-title":"Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms","volume":"127","author":"Araki","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jbior.2023.100993_bib6","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/bloodadvances.2021006325","article-title":"Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs","volume":"6","author":"Asimomitis","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/0975-1483.66810","article-title":"TGN1412: from discovery to disaster","volume":"2","author":"Attarwala","year":"2010","journal-title":"J. Young Pharm."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/hum.2016.024","article-title":"Fish to learn: insights into blood development and blood disorders from zebrafish hematopoiesis","volume":"27","author":"Avagyan","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2022.12.001","article-title":"Clonal hematopoiesis and inflammation - the perpetual cycle","volume":"33","author":"Avagyan","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib11","doi-asserted-by":"crossref","first-page":"FSO63","DOI":"10.4155\/fso.15.63","article-title":"Animal models are essential to biological research: issues and perspectives","volume":"1","author":"Barre-Sinoussi","year":"2015","journal-title":"Future Sci OA"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3324\/haematol.2018.208488","article-title":"Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia","volume":"105","author":"Beke","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib13","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood.V96.9.3256","article-title":"Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation","volume":"96","author":"Bekri","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOH.0000000000000693","article-title":"IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies","volume":"29","author":"Bennett","year":"2022","journal-title":"Curr. Opin. Hematol."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001970","article-title":"The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts","volume":"3","author":"Boultwood","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","article-title":"Clonal hematopoiesis and evolution to hematopoietic malignancies","volume":"22","author":"Bowman","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7975","key":"10.1016\/j.jbior.2023.100993_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41586-023-06424-7","article-title":"Transient naive reprogramming corrects hiPS cells functionally and epigenetically","volume":"620","author":"Buckberry","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.seminhematol.2018.08.001","article-title":"Genetic and epigenetic determinants of AML pathogenesis","volume":"56","author":"Cai","year":"2019","journal-title":"Semin. Hematol."},{"issue":"22","key":"10.1016\/j.jbior.2023.100993_bib19","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13059-020-02058-4","article-title":"Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation","volume":"21","author":"Canu","year":"2020","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2008-06-161422","article-title":"Hematopoietic defects in the Ts1Cje mouse model of Down syndrome","volume":"113","author":"Carmichael","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib22","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2002-07-2006","article-title":"Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia","volume":"101","author":"Cazzola","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib23","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors","volume":"5","author":"Cerquozzi","year":"2015","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2003-03-0832","article-title":"Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells","volume":"102","author":"Chadwick","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11912-015-0489-2","article-title":"Unraveling myelodysplastic syndromes: current knowledge and future directions","volume":"18","author":"Chamseddine","year":"2016","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stemcr.2018.03.020","article-title":"Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs","volume":"10","author":"Chang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2016.11.018","article-title":"Human AML-iPSCs reacquire leukemic properties after differentiation and model clonal variation of disease","volume":"20","author":"Chao","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molcel.2017.12.029","article-title":"The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations","volume":"69","author":"Chen","year":"2018","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.2019004260","article-title":"Splicing factor mutations in hematologic malignancies","volume":"138","author":"Chen","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib32","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1038\/s41467-019-13666-5","article-title":"MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2010-02-269589","article-title":"Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation","volume":"116","author":"Cho","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13287-023-03305-8","article-title":"In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources","volume":"14","author":"Cho","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nbt.3388","article-title":"A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs","volume":"33","author":"Choi","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.celrep.2012.08.002","article-title":"Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures","volume":"2","author":"Choi","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbior.2023.100993_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78136","article-title":"Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations","volume":"11","author":"Choudhary","year":"2022","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib38","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/MCB.15.4.1968","article-title":"Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae","volume":"15","author":"Choulika","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.jbior.2023.100993_bib39","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.2021012652","article-title":"Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome","volume":"139","author":"Clough","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/MCB.18.3.1444","article-title":"I-SceI-induced gene replacement at a natural locus in embryonic stem cells","volume":"18","author":"Cohen-Tannoudji","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molcel.2019.01.024","article-title":"R-loops as cellular regulators and genomic threats","volume":"73","author":"Crossley","year":"2019","journal-title":"Mol. Cell"},{"issue":"13","key":"10.1016\/j.jbior.2023.100993_bib42","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2016-06-724500","article-title":"Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel","volume":"129","author":"de Witte","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2017.03.009","article-title":"Large-scale profiling reveals the influence of genetic variation on gene expression in human induced pluripotent stem cells","volume":"20","author":"DeBoever","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib46","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2014.331","article-title":"Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells","volume":"29","author":"Dolatshad","year":"2015","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib47","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","article-title":"Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes","volume":"30","author":"Dolatshad","year":"2016","journal-title":"Leukemia"},{"issue":"6213","key":"10.1016\/j.jbior.2023.100993_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/2643-3230.BCD-23-0041","article-title":"iPSC models of leukemia come of age","volume":"4","author":"Doulatov","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","article-title":"Hematopoiesis: a human perspective","volume":"10","author":"Doulatov","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib51","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2009.12.001","article-title":"Vitamin C enhances the generation of mouse and human induced pluripotent stem cells","volume":"6","author":"Esteban","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib53","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3324\/haematol.2020.254193","article-title":"Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations","volume":"106","author":"Flach","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jbior.2023.100993_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.scr.2018.07.001","article-title":"Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL","volume":"31","author":"Gagne","year":"2018","journal-title":"Stem Cell Res."},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"issue":"24","key":"10.1016\/j.jbior.2023.100993_bib56","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood-2013-01-478412","article-title":"Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia","volume":"121","author":"Gandre-Babbe","year":"2013","journal-title":"Blood"},{"issue":"16_Suppl. l","key":"10.1016\/j.jbior.2023.100993_bib57","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1200\/JCO.2022.40.16_suppl.7016","article-title":"Phase 1\/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed\/refractory (R\/R) acute myeloid leukemia or lyelodysplastic syndrome","volume":"40","author":"Garcia-Manero","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"7681","key":"10.1016\/j.jbior.2023.100993_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib59","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.039321","article-title":"Modeling blood diseases with human induced pluripotent stem cells","volume":"12","author":"Georgomanoli","year":"2019","journal-title":"Dis Model Mech"},{"issue":"5939","key":"10.1016\/j.jbior.2023.100993_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/science.1172447","article-title":"Knockout rats via embryo microinjection of zinc-finger nucleases","volume":"325","author":"Geurts","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/stcltm\/szad022","article-title":"Reprogramming of acute myeloid leukemia patients cells: harboring cancer mutations requires targeting of AML hierarchy","volume":"12","author":"Golubeva","year":"2023","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm.3853","article-title":"Translational value of mouse models in oncology drug development","volume":"21","author":"Gould","year":"2015","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib63","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.stem.2010.06.015","article-title":"Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells","volume":"7","author":"Guenther","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2014.01.020","article-title":"Nonstochastic reprogramming from a privileged somatic cell state","volume":"156","author":"Guo","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"7284","key":"10.1016\/j.jbior.2023.100993_bib67","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature08735","article-title":"Tbx3 improves the germ-line competency of induced pluripotent stem cells","volume":"463","author":"Han","year":"2010","journal-title":"Nature"},{"issue":"7273","key":"10.1016\/j.jbior.2023.100993_bib68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature08592","article-title":"Direct cell reprogramming is a stochastic process amenable to acceleration","volume":"462","author":"Hanna","year":"2009","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.jbior.2023.100993_bib69","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","article-title":"Myelodysplasia","volume":"340","author":"Heaney","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101199","article-title":"Spliceosomal factor mutations and mis-splicing in MDS","volume":"33","author":"Hershberger","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib71","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41375-020-1002-y","article-title":"Complex landscape of alternative splicing in myeloid neoplasms","volume":"35","author":"Hershberger","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081195","article-title":"Inducible MLL-AF9 expression drives an AML program during human pluripotent stem cell-derived hematopoietic differentiation","volume":"12","author":"Heuts","year":"2023","journal-title":"Cells"},{"issue":"6146","key":"10.1016\/j.jbior.2023.100993_bib73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1239278","article-title":"Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds","volume":"341","author":"Hou","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.2018884338","article-title":"Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes","volume":"134","author":"Hsu","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib75","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nbt1418","article-title":"Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib77","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nbt.1502","article-title":"Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41588-021-00828-9","article-title":"Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition","volume":"53","author":"Inoue","year":"2021","journal-title":"Nat. Genet."},{"issue":"6096","key":"10.1016\/j.jbior.2023.100993_bib79","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.jbior.2023.100993_bib80","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2017-02-692715","article-title":"How do messenger RNA splicing alterations drive myelodysplasia?","volume":"129","author":"Joshi","year":"2017","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.jbior.2023.100993_bib81","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.1209979109","article-title":"Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells","volume":"109","author":"Kajiwara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib83","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2012.11.003","article-title":"T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures","volume":"2","author":"Kennedy","year":"2012","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib84","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2006-09-047704","article-title":"Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures","volume":"109","author":"Kennedy","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib85","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7658","key":"10.1016\/j.jbior.2023.100993_bib86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature22403","article-title":"Common genetic variation drives molecular heterogeneity in human iPSCs","volume":"546","author":"Kilpinen","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib87","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"issue":"7313","key":"10.1016\/j.jbior.2023.100993_bib88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib89","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"7603","key":"10.1016\/j.jbior.2023.100993_bib90","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1158\/2643-3230.BCD-22-0167","article-title":"Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia","volume":"4","author":"Kotini","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib92","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nbt.3178","article-title":"Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells","volume":"33","author":"Kotini","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib93","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"26","key":"10.1016\/j.jbior.2023.100993_bib94","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1182\/blood-2011-07-367441","article-title":"Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples","volume":"119","author":"Kumano","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","article-title":"Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential","volume":"6","author":"Kyttala","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jbior.2023.100993_bib96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exphem.2016.12.009","article-title":"Hemangioblast, hemogenic endothelium, and primitive versus definitive hematopoiesis","volume":"49","author":"Lacaud","year":"2017","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.seminhematol.2013.03.025","article-title":"Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models","volume":"50","author":"Larochelle","year":"2013","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib98","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","article-title":"Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture","volume":"8","author":"Laurent","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib99","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/stem.2655","article-title":"Brief report: human acute myeloid leukemia reprogramming to pluripotency is a rare event and selects for patient hematopoietic cells devoid of leukemic mutations","volume":"35","author":"Lee","year":"2017","journal-title":"Stem Cell."},{"key":"10.1016\/j.jbior.2023.100993_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25312","article-title":"Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering","volume":"6","author":"Lee","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.jbior.2023.100993_bib101","article-title":"Cellular reprogramming with multigene activation by the delivery of CRISPR\/dCas9 ribonucleoproteins via magnetic peptide-imprinted chitosan nanoparticles","volume":"9","author":"Lee","year":"2021","journal-title":"Mater Today Bio"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib102","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cell.2005.06.008","article-title":"Inactivation of the SR protein splicing factor ASF\/SF2 results in genomic instability","volume":"122","author":"Li","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/cr.2010.142","article-title":"Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules","volume":"21","author":"Li","year":"2011","journal-title":"Cell Res."},{"issue":"33","key":"10.1016\/j.jbior.2023.100993_bib104","doi-asserted-by":"crossref","first-page":"25516","DOI":"10.1074\/jbc.M110.142059","article-title":"Butyrate promotes induced pluripotent stem cell generation","volume":"285","author":"Liang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbior.2023.100993_bib106","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"issue":"7336","key":"10.1016\/j.jbior.2023.100993_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","article-title":"Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells","volume":"471","author":"Lister","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2023.100993_bib108","first-page":"1","article-title":"Human disease models in drug development","author":"Loewa","year":"2023","journal-title":"Nat Rev Bioeng"},{"issue":"16","key":"10.1016\/j.jbior.2023.100993_bib109","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biotechadv.2017.11.008","article-title":"Harnessing CRISPR\/Cas systems for programmable transcriptional and post-transcriptional regulation","volume":"36","author":"Mahas","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.jbior.2023.100993_bib111","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib112","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2014-03-560227","article-title":"Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia","volume":"124","author":"Malcovati","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jbior.2023.100993_bib113","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","article-title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jbior.2023.100993_bib114","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat. Methods"},{"issue":"6121","key":"10.1016\/j.jbior.2023.100993_bib115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib116","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1634\/stemcells.2008-0346","article-title":"Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts","volume":"26","author":"Mali","year":"2008","journal-title":"Stem Cell."},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib117","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib118","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.stem.2010.07.017","article-title":"Identification and classification of chromosomal aberrations in human induced pluripotent stem cells","volume":"7","author":"Mayshar","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib119","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1371\/journal.pbio.0020234","article-title":"Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences","volume":"2","author":"Mitchell","year":"2004","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib120","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.stemcr.2018.01.015","article-title":"ADAM8 is an antigen of tyrosine kinase inhibitor-resistant chronic myeloid leukemia cells identified by patient-derived induced pluripotent stem cells","volume":"10","author":"Miyauchi","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib121","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nprot.2010.173","article-title":"Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors","volume":"6","author":"Narsinh","year":"2011","journal-title":"Nat. Protoc."},{"issue":"18","key":"10.1016\/j.jbior.2023.100993_bib122","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-17-3970","article-title":"Spliceosome mutations induce R loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes","volume":"78","author":"Nguyen","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib123","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/leu.2012.298","article-title":"The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts","volume":"27","author":"Nikpour","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib124","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1038\/s41598-021-83895-6","article-title":"Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model","volume":"11","author":"Nilsri","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2016.06.019","article-title":"Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity","volume":"19","author":"Nishizawa","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18921-2","article-title":"Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome","volume":"12","author":"Ochi","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jbior.2023.100993_bib128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nprot.2009.231","article-title":"Generation of mouse-induced pluripotent stem cells with plasmid vectors","volume":"5","author":"Okita","year":"2010","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib130","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.stemcr.2021.09.019","article-title":"CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes","volume":"16","author":"Olschok","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib131","article-title":"hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia","volume":"3","author":"Pal","year":"2022","journal-title":"Cell Rep Med"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092120","article-title":"Genetic aspects of myelodysplastic\/myeloproliferative neoplasms","volume":"13","author":"Palomo","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.jbior.2023.100993_bib133","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.2019004229","article-title":"Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms","volume":"136","author":"Palomo","year":"2020","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jbior.2023.100993_bib134","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.jbior.2023.100993_bib135","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.jbior.2023.100993_bib136","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045812","article-title":"Efficient generation of virus-free iPS cells using liposomal magnetofection","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"issue":"7175","key":"10.1016\/j.jbior.2023.100993_bib138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib139","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/leu.2017.164","article-title":"Genomic determinants of chronic myelomonocytic leukemia","volume":"31","author":"Patel","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.25684","article-title":"Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management","volume":"95","author":"Patnaik","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib141","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ajh.26455","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib142","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stemcr.2015.01.003","article-title":"In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation","volume":"4","author":"Pearson","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib143","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1242\/dev.011767","article-title":"The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF","volume":"135","author":"Pearson","year":"2008","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib144","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","article-title":"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations","volume":"132","author":"Pellagatti","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.12515","article-title":"The molecular pathogenesis of the myelodysplastic syndromes","volume":"95","author":"Pellagatti","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jbior.2023.100993_bib146","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbior.2016.08.001","article-title":"Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications","volume":"63","author":"Pellagatti","year":"2017","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2023.100993_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.100655","article-title":"Splicing factor mutant myelodysplastic syndromes: recent advances","volume":"75","author":"Pellagatti","year":"2020","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.jbior.2023.100993_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2022.100920","article-title":"Splicing factor mutations in the myelodysplastic syndromes: role of key aberrantly spliced genes in disease pathophysiology and treatment","volume":"87","author":"Pellagatti","year":"2023","journal-title":"Adv Biol Regul"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib149","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/leu.2015.129","article-title":"Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression","volume":"30","author":"Pellagatti","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib151","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1074\/jbc.R113.516419","article-title":"Genomic instability in pluripotent stem cells: implications for clinical applications","volume":"289","author":"Peterson","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib152","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1634\/stemcells.2006-0713","article-title":"Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis","volume":"25","author":"Pick","year":"2007","journal-title":"Stem Cell."},{"issue":"22","key":"10.1016\/j.jbior.2023.100993_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225666","article-title":"The classification of myeloproliferative neoplasms: rationale, historical background and future perspectives with focus on unclassifiable cases","volume":"13","author":"Pizzi","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib154","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","article-title":"Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells","volume":"28","author":"Polo","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00428-022-03465-7","article-title":"Advances in myelodysplastic\/myeloproliferative neoplasms","volume":"482","author":"Prakash","year":"2023","journal-title":"Virchows Arch."},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113250","article-title":"Induced pluripotent stem cells as a tool for modeling hematologic disorders and as a potential source for cell-based therapies","volume":"10","author":"Pratumkaew","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib157","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib158","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib159","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.seminhematol.2015.03.008","article-title":"Biology and clinical relevance of acute myeloid leukemia stem cells","volume":"52","author":"Reinisch","year":"2015","journal-title":"Semin. Hematol."},{"issue":"7381","key":"10.1016\/j.jbior.2023.100993_bib160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10761","article-title":"The promise of induced pluripotent stem cells in research and therapy","volume":"481","author":"Robinton","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib161","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2016.05.016","article-title":"Engineering hematopoietic stem cells: lessons from development","volume":"18","author":"Rowe","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib162","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cub.2010.11.049","article-title":"A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity","volume":"21","author":"Ruiz","year":"2011","journal-title":"Curr. Biol."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074257","article-title":"Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients","volume":"8","author":"Saliba","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib164","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.stem.2008.05.011","article-title":"A combined chemical and genetic approach for the generation of induced pluripotent stem cells","volume":"2","author":"Shi","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib166","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib167","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/s41375-020-0753-9","article-title":"SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications","volume":"34","author":"Singh","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib168","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.exphem.2015.06.007","article-title":"Pathogenesis of myeloproliferative neoplasms","volume":"43","author":"Skoda","year":"2015","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib169","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2023.100993_bib170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exphem.2017.05.007","article-title":"Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia","volume":"53","author":"Sloma","year":"2017","journal-title":"Exp. Hematol."},{"issue":"25","key":"10.1016\/j.jbior.2023.100993_bib171","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1182\/blood-2013-07-474825","article-title":"Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells","volume":"122","author":"Slukvin","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib172","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41556-019-0314-5","article-title":"U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies","volume":"21","author":"Smith","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6034","key":"10.1016\/j.jbior.2023.100993_bib173","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","article-title":"Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination","volume":"317","author":"Smithies","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2023.100993_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2022.101920","article-title":"Polycomb complexes in MLL-AF9-related leukemias","volume":"75","author":"Sparavier","year":"2022","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"5903","key":"10.1016\/j.jbior.2023.100993_bib176","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib177","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.mayocp.2015.04.001","article-title":"Myelodysplastic syndromes: diagnosis and treatment","volume":"90","author":"Steensma","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib178","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.jbior.2023.100993_bib179","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41388-019-0813-7","article-title":"Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation","volume":"38","author":"Stetka","year":"2019","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.jbior.2023.100993_bib180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.2021015162","article-title":"Inflammation and myeloid malignancy: quenching the flame","volume":"140","author":"Stubbins","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib181","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nbt.2571","article-title":"Defining the path to hematopoietic stem cells","volume":"31","author":"Sturgeon","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib182","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/mt.2013.71","article-title":"Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation","volume":"21","author":"Suzuki","year":"2013","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib183","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib184","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib185","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjh.15266","article-title":"Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations","volume":"181","author":"Takei","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib186","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34193-1","article-title":"Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate","volume":"8","author":"Taoka","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib187","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41375-018-0169-y","article-title":"Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells","volume":"33","author":"Tasian","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib188","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.jbior.2023.100993_bib189","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092594","article-title":"Modeling global genomic instability in chronic myeloid leukemia (CML) using patient-derived induced pluripotent stem cells (iPSCs)","volume":"15","author":"Telliam","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib191","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.1940","article-title":"Knockout rats generated by embryo microinjection of TALENs","volume":"29","author":"Tesson","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib192","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.stem.2014.09.003","article-title":"Systematic identification of culture conditions for induction and maintenance of naive human pluripotency","volume":"15","author":"Theunissen","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.jbior.2023.100993_bib193","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"issue":"5391","key":"10.1016\/j.jbior.2023.100993_bib194","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jbior.2023.100993_bib195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/10428194.2017.1357179","article-title":"Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes","volume":"59","author":"Thota","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.jbior.2023.100993_bib196","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/gt.2010.47","article-title":"Large animal models of hematopoietic stem cell gene therapy","volume":"17","author":"Trobridge","year":"2010","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.jbior.2023.100993_bib197","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib198","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jbior.2023.100993_bib199","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2014-10-570234","article-title":"De novo generation of HSCs from somatic and pluripotent stem cell sources","volume":"125","author":"Vo","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib200","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jbior.2023.100993_bib201","doi-asserted-by":"crossref","DOI":"10.1242\/bio.047225","article-title":"NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities","volume":"8","author":"Wang","year":"2019","journal-title":"Biol Open"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib202","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.stem.2011.10.005","article-title":"The histone demethylases Jhdm1a\/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner","volume":"9","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib204","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt1310","article-title":"A ROCK inhibitor permits survival of dissociated human embryonic stem cells","volume":"25","author":"Watanabe","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107688","article-title":"Acute myeloid leukemia iPSCs reveal a role for RUNX1 in the maintenance of human leukemia stem cells","volume":"31","author":"Wesely","year":"2020","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib207","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-21-0508","article-title":"Integrative RNA-omics discovers GNAS alternative splicing as a phenotypic driver of splicing factor-mutant neoplasms","volume":"12","author":"Wheeler","year":"2022","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.jbior.2023.100993_bib208","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","article-title":"Cancer cell lines for drug discovery and development","volume":"74","author":"Wilding","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib209","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","article-title":"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo","volume":"25","author":"Woll","year":"2014","journal-title":"Cancer Cell"},{"issue":"7239","key":"10.1016\/j.jbior.2023.100993_bib210","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.jbior.2023.100993_bib211","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood-2012-02-412296","article-title":"The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jbior.2023.100993_bib212","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1002\/ajh.23541","article-title":"Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression","volume":"88","author":"Wu","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jbior.2023.100993_bib213","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.genet.40.110405.090451","article-title":"DNA double-strand break repair: all's well that ends well","volume":"40","author":"Wyman","year":"2006","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.jbior.2023.100993_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102096","article-title":"An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects","volume":"49","author":"Yamasaki","year":"2020","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.jbior.2023.100993_bib215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/stem.1545","article-title":"Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells","volume":"32","author":"Ye","year":"2014","journal-title":"Stem Cell."},{"issue":"27","key":"10.1016\/j.jbior.2023.100993_bib216","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","article-title":"Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders","volume":"114","author":"Ye","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jbior.2023.100993_bib217","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1172\/JCI91363","article-title":"The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes","volume":"127","author":"Yip","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"7367","key":"10.1016\/j.jbior.2023.100993_bib218","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"7777","key":"10.1016\/j.jbior.2023.100993_bib219","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-019-1618-0","article-title":"Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis","volume":"574","author":"Yoshimi","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib220","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.stem.2012.03.002","article-title":"Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells","volume":"10","author":"Young","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"5858","key":"10.1016\/j.jbior.2023.100993_bib221","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jbior.2023.100993_bib222","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2004-11-4522","article-title":"Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development","volume":"106","author":"Zambidis","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jbior.2023.100993_bib223","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.stem.2008.10.002","article-title":"Two supporting factors greatly improve the efficiency of human iPSC generation","volume":"3","author":"Zhao","year":"2008","journal-title":"Cell Stem Cell"}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492623000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492623000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:29:07Z","timestamp":1761949747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492623000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":223,"alternative-id":["S2212492623000398"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2023.100993","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2023.100993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100993"}}